Search - tctmd.com

Displaying 801 - 820 of 2052

Sort: Relevancy | Date

Presentation TCT 2017

Italy Presents a Case: STEMI Due to Left Main Disease

Presenter: Graham A. Cassel, Haim Danenberg, Giuseppe Tarantini, Ugo Limbruno

October 30, 2017

Presentation TCT 2017

Bulgaria Presents: How I Treated This Complex ACS Case

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Ivo Petrov

October 30, 2017

Presentation TCT 2017

Romania Presents: How Should I Treat This Complex ACS Case?

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Marin Postu

October 30, 2017

Presentation TCT 2017

Bulgaria Presents: My Worst Complication During ACS PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa, Ivo Petrov

October 30, 2017

Presentation TCT 2017

Romania Presents: Complications That Can Occur During ACS PCI

Presenter: Valeri L Gelev, Michael Kang-Yin Lee, Stefan Mot, Zoltan Ruzsa

October 30, 2017

Presentation TCT 2017

Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

Presenter: John A. Bittl, Freek W.A. Verheugt, Somjot S. Brar

October 30, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Presentation TCT 2017

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

Presenter: John A. Bittl, Freek W.A. Verheugt, Dimitrios Alexopoulos

October 30, 2017

Presentation TCT 2017

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Presenter: John A. Bittl, Freek W.A. Verheugt, Patricia J. Best

October 30, 2017

Presentation TCT 2017

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Presenter: Thomas H. Maloney, C. Michael Gibson

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Presenter: Michael S. Lee, Dirk Sibbing, John A. Bittl

October 30, 2017

Presentation TCT 2017

Case Presentation Introduction: STEMI/ACS

Presenter: Thomas H. Maloney, Jaya Chandrasekhar

October 30, 2017

Presentation TCT 2017

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge

October 30, 2017

Presentation TCT 2017

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Presenter: Thomas H. Maloney, Connie N. Hess

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Why I Use Cangrelor for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Dmitriy N. Feldman

October 30, 2017

Presentation TCT 2017

Why I Prefer Bivalirudin for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Uwe Zeymer

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Presenter: Michael S. Lee, Dirk Sibbing, Eric R. Bates

October 30, 2017

Advertisement

Italy Presents a Case: STEMI Due to Left Main Disease

Bulgaria Presents: How I Treated This Complex ACS Case

Romania Presents: How Should I Treat This Complex ACS Case?

Bulgaria Presents: My Worst Complication During ACS PCI

Romania Presents: Complications That Can Occur During ACS PCI

Debate: Making the Case for Not Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Debate: Making the Case for Pretreating ACS patients With Oral P2Y12 Receptor Inhibitors!

NSTEMI Case Presentation: Why the DAPT Pre-load Decision Matters

Atrial Fibrillation and PCI/ACS: NOACs, Dual Therapy, and Triple Therapy

Case Resolution: STEMI/ACS

Should Choice of Parenteral Therapy for Primary PCI in STEMI Depend on Vascular Access?

Case Presentation Introduction: STEMI/ACS

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

What Is the Next Quality Indicator to Improve Outcomes in STEMI?

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Why I Use Cangrelor for Primary PCI in STEMI!

Why I Prefer Bivalirudin for Primary PCI in STEMI!

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Why I Prefer a Heparin Plus a GPI for Primary PCI in STEMI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content